Dzone - DevOps
MARCH 20, 2025
Multidomain integration is becoming a cornerstone of modern software development, bridging technologies like blockchain, biotech, and consumer applications. These cross-domain projects are no longer optional they are the future of innovation. However, combining such diverse systems presents unique challenges.
Crunchbase News
APRIL 2, 2024
Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. That makes it quite the month for startups looking to develop drugs and therapies for all that ails us. Check out the biggest rounds of last month here. billion, per Crunchbase.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Crunchbase News
APRIL 25, 2025
Chainguard , $356M, cybersecurity: Software supply chain security startup Chainguard raised a massive $356 million Series D at a valuation of $3.5 billion as companies look for ways to secure software development. The new funding was co-led by new investor Kleiner Perkins and existing investor IVP.
Crunchbase News
SEPTEMBER 6, 2024
Arsenal Biosciences , $325M, biotech: The big biotech raise of the week went to South San Francisco-based Arsenal Biosciences. eGenesis , $191M, biotech: Cambridge, Massachusetts-based eGenesis, a biotech firm developing human-compatible engineered organs, closed a $191 million Series D led by Lux Capital.
TechCrunch
FEBRUARY 4, 2022
Among the portfolio of companies, the firm has invested in email security company Abnormal Security , which raised $50 million back in 2020; biotech software developer Benchling , which raised $100 million in Series F funding last November; and Transmit Security , which took in a $543 million Series A last year on a pre-money valuation of $2.2
Crunchbase News
APRIL 12, 2024
Torl BioTherapeutics , $158M, biotech: It was just about a year ago that Los Angeles-based biopharmaceutical company Torl BioTherapeutics closed a $158 million Series B led by Goldman Sachs Asset Management. Well, the cancer-treating biotech is back this week after it closed a B-2 financing at another $158 million led by Deep Track Capital.
CIO
APRIL 17, 2024
Helping software developers write and test code Similarly in tech, companies are currently open about some of their use cases, but protective of others. Gen AI helps scientists develop new proteins Another interesting set of use cases can be found, for the time being, in biotech.
Expert insights. Personalized for you.
52 
Let's personalize your content